Immunology and Microbiology
Acinetobacter Baumannii
92%
Airway
26%
Antibiotic Resistance
31%
Antibiotic Sensitivity
32%
Antifungal Resistance
26%
Antifungal Susceptibility
8%
Antimicrobial Activity
26%
Antimicrobial Agent
26%
Antimicrobial Peptides
26%
Asthma
29%
Biofilm
26%
Blood Flow
13%
Broth Dilution
12%
Campylobacter
13%
Campylobacter Coli
6%
Campylobacter Jejuni
6%
Candida
18%
Candida albicans
17%
Cohort Effect
18%
Coinfection
8%
COVID-19
13%
Cross-Reactivity
6%
Dermatophyte
13%
Dysbiosis
26%
Gene Insertion Sequence
8%
Gene Overexpression
8%
Genetic Variability
26%
Human Microbiome
6%
Hydrogen Peroxide
26%
Infection
100%
Infectious Agent
11%
Melittin
26%
Methicillin-Resistant Staphylococcus Aureus
26%
Microbiome
30%
Microflora
15%
Minimum Inhibitory Concentration
23%
Multidrug Resistance
7%
Multidrug-Resistant Pathogen
26%
Multiplex Polymerase Chain Reaction
13%
Pseudomonas aeruginosa
39%
Scanning Electron Microscopy
9%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Species Differentiation
8%
Susceptibility
47%
Tocilizumab
8%
Trauma
6%
Trichophyton
10%
Turnaround Time
6%
Virus Genome
13%
Whole Genome Sequencing
13%
Medicine and Dentistry
7,12 Dimethylbenz[a]anthracene
26%
Acinetobacter Baumannii
42%
Acinetobacter Infection
26%
Acute Lymphoblastic Leukemia
26%
Agar
17%
Antibiogram
19%
Antibiotic Resistance
29%
Antifungal Resistance
6%
Antiinfective Agent
8%
Antimicrobial Activity
26%
Antimicrobial Agent
26%
Avibactam Plus Ceftazidime
26%
Bloodstream Infection
13%
Candidemia
13%
Cefepime
14%
Ceftazidime
14%
Ceftolozane
26%
Ciprofloxacin
8%
COVID-19
6%
Effusion
6%
Escherichia coli
8%
Genetic Variability
26%
Genomic Island
6%
Gram-Negative Bacteria
29%
Hydrogen Peroxide
26%
Imipenem
45%
Infection
25%
Infection Control
12%
Intensive Care Unit
35%
Itraconazole
8%
Lactam
5%
Leukemia
17%
Levofloxacin
8%
Linezolid
5%
Meropenem
20%
Metallo Beta Lactamase
26%
Methicillin Resistant Staphylococcus Aureus Infection
26%
Multidrug Resistance
12%
Penicillinase
33%
Piperacillin/Tazobactam
14%
Posaconazole
8%
Prevalence
26%
Pseudomonas aeruginosa
44%
Quinolone Derivative
5%
Rifampicin
5%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Tazobactam
26%
Tigecycline
8%
Virus Genome
13%
Whole Genome Sequencing
26%
Biochemistry, Genetics and Molecular Biology
23S Ribosomal RNA
8%
Acinetobacter Baumannii
79%
Agar
5%
Amino Acid
6%
Anidulafungin
8%
Antibiotic Resistance
18%
Antifungal Resistance
26%
Antifungal Susceptibility
8%
Antimicrobial Peptides
26%
Beta-Lactamase
26%
Biochemical Testing
6%
Biofilm
26%
Bloodstream Infection
26%
CagA
8%
Campylobacter
26%
Campylobacter Coli
6%
Campylobacter Jejuni
6%
Ceftazidime
29%
Congo Red
5%
Cross Resistance
8%
Cross Sectional Study
5%
Echinocandin
8%
Enterobacter
6%
Escherichia coli
6%
Flucytosine
8%
Genetic Divergence
26%
Genetics
33%
Genomics
6%
Genotyping
9%
Gram Negative Bacterium
33%
Helicobacter pylori
13%
Imipenem
29%
Infectious Agent
29%
Intravenous Immunoglobulin
6%
Melittin
26%
Micafungin
8%
Minimum Inhibitory Concentration
9%
Multidrug Resistance
13%
Multiplex Polymerase Chain Reaction
13%
Prevalence
26%
Pseudomonas aeruginosa
29%
Relatedness
6%
Scanning Electron Microscopy
9%
Species Differentiation
8%
Tazobactam
29%
Tissue Culture
5%
Turnaround Time
6%
Virulence Gene
13%
Whole Genome Sequencing
26%